Curie.Bio

Curie.Bio is a founder-focused seed-stage venture capital firm. We built Curie.Bio to free the founders. Curie.Bio significantly improves your ability to create impactful medicines while minimizing long-term dilution. Our unparalleled team and capital-efficient model provide you with immediate access to the industry’s top drug hunters, operators, and R&D services from day one. With better planning and more progress at the seed and Series A stage, you’ll have a significantly higher chance of a future where you retain agency and upside from your company’s success. We’ve raised nearly $1 billion to provide founders with the world’s best people and to fund their companies from the idea stage to meaningful clinical data.